Fiera Capital Corp Buys Shares of 23,869 Balchem Co. (NASDAQ:BCPC)

Fiera Capital Corp acquired a new position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 23,869 shares of the basic materials company's stock, valued at approximately $4,201,000. Fiera Capital Corp owned about 0.07% of Balchem at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of BCPC. Janus Henderson Group PLC lifted its stake in Balchem by 21.3% in the 1st quarter. Janus Henderson Group PLC now owns 18,059 shares of the basic materials company's stock valued at $2,795,000 after purchasing an additional 3,176 shares during the last quarter. Quantbot Technologies LP acquired a new stake in Balchem in the 1st quarter valued at about $495,000. William Blair Investment Management LLC lifted its position in Balchem by 8.4% during the second quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company's stock worth $35,998,000 after acquiring an additional 18,104 shares during the last quarter. Oppenheimer Asset Management Inc. lifted its position in Balchem by 22.1% during the second quarter. Oppenheimer Asset Management Inc. now owns 20,582 shares of the basic materials company's stock worth $3,169,000 after acquiring an additional 3,732 shares during the last quarter. Finally, Envestnet Asset Management Inc. lifted its position in Balchem by 9.9% during the second quarter. Envestnet Asset Management Inc. now owns 114,253 shares of the basic materials company's stock worth $17,589,000 after acquiring an additional 10,285 shares during the last quarter. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have issued reports on BCPC shares. StockNews.com upgraded shares of Balchem from a "hold" rating to a "buy" rating in a research report on Monday, October 28th. HC Wainwright raised their target price on shares of Balchem from $185.00 to $190.00 and gave the stock a "buy" rating in a report on Monday, November 4th.

Balchem Stock Performance

Shares of BCPC traded up $2.69 during mid-day trading on Friday, hitting $179.32. 135,783 shares of the company's stock were exchanged, compared to its average volume of 122,450. Balchem Co. has a 52 week low of $116.84 and a 52 week high of $186.03. The stock's 50-day simple moving average is $172.12 and its 200-day simple moving average is $164.41. The firm has a market cap of $5.83 billion, a price-to-earnings ratio of 48.20, a price-to-earnings-growth ratio of 5.48 and a beta of 0.65. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.